Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesPatent Strategies for Foreign R&D Work in China
By Philip Brooks
On December 27, 2009, the Standing Committee of the National People's Congress passed the amendments to the Patent Act. Tian Junfeng, an attorney with Unitalen Attorneys at Law, analyzed China's Patent Law and Foreign Trade Law and shares some insights in this article. China Business Weekly will run the article in several issues. Below is an excerpt from the first part of it which appeared in the January 12, 2009 issue of China Daily:
Numerous multinational companies, such as Microsoft, IBM, Lucent, Hewlett-Packard, Samsung, Philips, Motorola, Nokia, have established their R&D centers in China, respectively. Up to now, the number of foreign companies that have set up R & D centers in China has exceeded 1,000.
Most of these companies are ranked in the world top 500. They established their R&D centers in China in order to meet demands for localization of products, technologies and services, and to promote their enterprise image. They also want to sharpen their competitive edge in the local market by exploiting the rich human resources of technical professionals and taking advantage of the low capital costs. This has become an important part of their localization strategy.
Although these R&D centers are playing an ever-important role in technological innovation and making great achievements, they have encountered all sorts of problems in implementing their patent strategies so as to better protect their R&D achievements. One of the outstanding problems is how to transfer their technological breakthroughs abroad.
Regarding this issue, there are relevant provisions in China's Patent Law, the Foreign Trade Law and others.
Mr. Junfeng goes on to discuss the implications of Articles 8, 10 and 20 of the Patent Law on R&D. See the full article here.
Full post as published by Philip Brooks’ Patent Infringement Updates on January 13, 2009 (boomark / email).
Dumb Foreign Laws
Stupid Laws of Other Countries
Work Visas
Types of work permits
Temporary Work Visas
Differences Between H-1B, J-1, E-1, E-2, L-1, and R-1 Work Visas
Foreign Investment and National Security Act of 2007
Strengthens examination requirements of the Committee on Foreign Investment in the United States
H-1B Work Visa
H-1B Visa Assistance
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
China Green Agriculture, Inc. 401(k) / ERISA Stock Fraud
China Green Agriculture, Inc. 401(k) / ERISA Stock Fraud
Arkansas Nucor Plant Guilty of a Racially Hostile Work Environment
Nucor Guilty Of Racially Hostile Work Environment Must Pay $1.2 Million Settlement
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Infant Formula From China
FDA Warns it May be Contaminated Melamine
Schwan's Frozen Chicken
Recalled for Foreign Materials

Foreign Companies In China Can't Get No Love
Hold Up There On That Outsourcing of Patent Work
Patent Challenge in China: What's the State of the Art
Int'l Patent Litigation - Winning Strategies
"No love" in China for foreign corps.
Patent Counsel - Large Corporation - San Diego, Calif.









